Abstract
Mandibular distraction osteogenesis (MDO) is an effective treatment for obstructive sleep apnea (OSA) in infants with microretrognathia1; this is particularly beneficial for patients with isolated Pierre Robin sequence (iPRS). Without intervention to improve the upper airway, patients may require tracheostomy. It is generally accepted that these patients develop with disproportionate maxillomandibular growth postdistraction; yet, the timeline for relapse to class II and differences across sexes are not well-described.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
